Carlo Pozzilli | Ricerc@Sapienza

Publications

Title	Published on	Year
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis	AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY	2021
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases	FRONTIERS IN NEUROLOGY	2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2021
Ponesimod to treat multiple sclerosis	DRUGS OF TODAY	2021
Multi-scale resting state functional reorganization in response to multiple sclerosis damage	NEURORADIOLOGY	2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2020
Resting-state functional connectivity of anterior and posterior cerebellar lobes is altered in multiple sclerosis	MULTIPLE SCLEROSIS	2020
Cesarean section in women with MS: A choice or a need?	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2020
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial	NEUROTHERAPEUTICS	2020
Multiple sclerosis treatment and melanoma development	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020
A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis	FRONTIERS IN NEUROLOGY	2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors	MULTIPLE SCLEROSIS	2020
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET NEUROLOGY	2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis	BRAIN	2020
Ofatumumab versus Teriflunomide in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE	2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study	CNS DRUGS	2020
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges	MULTIPLE SCLEROSIS	2020
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study	NEUROLOGICAL SCIENCES	2020
Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies	MULTIPLE SCLEROSIS	2020
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis	CLINICAL DRUG INVESTIGATION	2020